October 20, 2014 / 2:18 PM / in 3 years

Valeant may raise Allergan bid, says it won't walk away

(Reuters) - Valeant Pharmaceuticals Inc (VRX.TO) may raise its hostile takeover bid for Allergan Inc (AGN.N) and will not walk away from its pursuit ahead of Allergan’s Dec. 18 special shareholder meeting, Chief Executive Michael Pearson said on Monday.

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec May 20, 2014. REUTERS/Christinne Muschi

Pearson also said speculation that Valeant’s relationship was strained with Pershing Square Capital Management, Allergan’s biggest shareholder, is false.

Reporting by Rod Nickel in Winnipeg, Manitoba Editing by W Simon

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below